Curemark, LLC
USPTO PatentsView assignee record - 39 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Curemark ranks #8,182 of 49,997 tracked US assignees by granted-patent volume, with 39 patents across 13 technology areas.
- #8,182
- of 49,997 US assignees by volume
- Top 35%
- by Innovation Score (40.5/100)
- 21.3
- avg claims per patent
- -64%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R8182 · US Corporation #8,182 · 39 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 39 grants
- UPPER-Q #8,182/49,997
- PHOTO-FINISH Cavendish Kinetics
- CPC-FOCUS A61K · 13 areas
- INNOV-PAR 40.5/100
- CLAIMS-DENSE 21.3 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -64% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Cavendish Kinetics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Curemark’s 40.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Curemark
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Curemark · this assignee
Curemark · this assignee
41 score
- GlassPoint Solar · near
GlassPoint Solar · near
41 score
- Katerra · near
Katerra · near
41 score
- McMaster-Carr Supply · near
McMaster-Carr Supply · near
41 score
- Robertson Intellectu… · near
Robertson Intellectu… · near
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Curemark's Innovation Score is 40.5/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Curemark?
Each dot is one of Curemark’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Curemark’s own 21.3 claims/patent is ABOVE the 17.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Curemark's grants concentrate
Curemark, LLC is a focused PatentsView assignee: 13 CPC subclasses with 92.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (9 grants) versus a trough of 1 in 2023. By volume, Curemark sits between Cavendish Kinetics, Inc. and Dsm&t Company Inc..
Curemark's three-year grant acceleration
Curemark, LLC shows 4 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Curemark's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Cavendish Kinetics
Cavendish Kinetics, Inc.
39 patents
- Cayenne Medical
Cayenne Medical, Inc.
39 patents
- Chemtron Research
Chemtron Research LLC
39 patents
- Conexant Systems
Conexant Systems, LLC
39 patents
- Cydex Pharmaceuti…
CyDex Pharmaceuticals, Inc.
39 patents
- Doheny EYE Instit…
Doheny EYE Institute
39 patents
- Dongjin Semichem
Dongjin Semichem Co., Ltd.
39 patents
- Dsm&t
Dsm&t Company Inc.
39 patents
- Curemark ◀
Curemark, LLC
39 patents
What this shows Curemark holds 39 patents at rank #8,183, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Curemark
By rank, the assignees closest to #8,183 in granted patent volume.
- Cavendish Kinetics, Inc. #8,179 · 39 patents
- Cayenne Medical, Inc. #8,180 · 39 patents
- Chemtron Research LLC #8,181 · 39 patents
- Conexant Systems, LLC #8,182 · 39 patents
- CyDex Pharmaceuticals, Inc. #8,184 · 39 patents
- Doheny EYE Institute #8,185 · 39 patents
- Dongjin Semichem Co., Ltd. #8,186 · 39 patents
- Dsm&t Company Inc. #8,187 · 39 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Curemark's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Curemark, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Curemark ranks #604 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (41 here).
Curemark's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 35% higher than 65% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 12.8% |
| 2016 | 9 | 23.1% |
| 2017 | 5 | 12.8% |
| 2018 | 3 | 7.7% |
| 2019 | 6 | 15.4% |
| 2020 | 2 | 5.1% |
| 2021 | 4 | 10.3% |
| 2022 | 3 | 7.7% |
| 2023 | 1 | 2.6% |
| 2025partial year | 1 | 2.6% |
Which technologies does Curemark, LLC patent most?
Top 13 of 13 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Curemark, LLC's patent record in context - here's where to go next.
- Curemark, LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 92.3% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #8,182 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Curemark, LLC against Cavendish Kinetics, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.